27 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Programme de rachat - December 2019 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/01/2020 | Monthly communication regarding buyback programs | |
2019 sales: €396.0 million (Up 7.6%) The Vetoquinol Group posted 2019 sales of €396.0 million, up 7.6% as reported and up 6.1% at constant exchange rates. |
23/01/2020 | Public releases | |
Programme de rachat - January 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
07/02/2020 | Monthly communication regarding buyback programs | |
Vetoquinol to acquire rights for Profender® and Drontal® from Elanco Animal Health for the European economic area and the UK February 12 th , 2020 (Lure, France) - Vetoquinol has agreed terms to acquire the European Economic area and UK rights to Profender® and Drontal® product families from Elanco Animal Health. |
12/02/2020 | Public releases | |
Programme de rachat - February 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
04/03/2020 | Monthly communication regarding buyback programs | |
Covid-19: Vetoquinol donates masks to neighboring healthcare facilities Vetoquinol S.A, the animal health laboratory based in Lure (70) has decided to donate more than 6000 masks to hospitals and associations in the region. This is a civic action to help, amongst others, hospitals in the Belfort Montbéliard, Vesoul and Saint-Rémy regions. |
20/03/2020 | Public releases | |
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (23 mars 2020) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
23/03/2020 | Monthly communication regarding buyback programs | |
2019 annual results: group sales €396.0M, up 6.1% at constant exchange rates. Net income group share: €28.6M (7.2% of sales) At its meeting on March 24, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the 2019 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon. |
26/03/2020 | Public releases | |
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (30 mars 2020) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
30/03/2020 | Monthly communication regarding buyback programs | |
Programme de rachat - March 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/04/2020 | Monthly communication regarding buyback programs |